Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed Feb 26, 2026 · 10-K · 57 days after period end · 0001193125-26-076650
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $0.00 |
| Net Income | -$105.26M | -$65.69M | -$44.74M | -$37.40M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 26, 2026 · 57 d after period end
